vs
Privia Health Group, Inc.（PRVA）与Rithm Capital Corp.（RITM）财务数据对比。点击上方公司名可切换其他公司
Rithm Capital Corp.的季度营收约是Privia Health Group, Inc.的1.5倍（$828.2M vs $541.2M），Rithm Capital Corp.净利率更高（13.2% vs 1.7%，领先11.5%），Rithm Capital Corp.同比增速更快（508.5% vs 17.4%），过去两年Privia Health Group, Inc.的营收复合增速更高（14.2% vs -17.9%）
Privia Health Group, Inc.是总部位于美国的医疗科技与服务企业，为独立诊所、医疗系统和医疗支付方提供价值导向型医疗解决方案，涵盖人群健康管理、患者互动平台、护理协调支持及行政流程优化工具，助力提升诊疗效果、降低医疗参与方运营成本。
Rithm Capital Corp.是总部位于美国纽约的投资管理机构，核心业务聚焦房地产投资与另类资产投资，依托专业的投研团队和成熟的市场运营经验，为合作伙伴及投资者提供优质的资产配置解决方案与长期收益回报。
PRVA vs RITM — 直观对比
营收规模更大
RITM
是对方的1.5倍
$541.2M
营收增速更快
RITM
高出491.1%
17.4%
净利率更高
RITM
高出11.5%
1.7%
两年增速更快
PRVA
近两年复合增速
-17.9%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $541.2M | $828.2M |
| 净利润 | $9.2M | $109.5M |
| 毛利率 | — | — |
| 营业利润率 | 2.1% | 29.9% |
| 净利率 | 1.7% | 13.2% |
| 营收同比 | 17.4% | 508.5% |
| 净利润同比 | 108.0% | 27.7% |
| 每股收益（稀释后） | $0.08 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PRVARITM
| Q1 26 | — | $828.2M | ||
| Q4 25 | $541.2M | $1.5B | ||
| Q3 25 | $580.4M | $1.1B | ||
| Q2 25 | $521.2M | $1.2B | ||
| Q1 25 | $480.1M | $768.4M | ||
| Q4 24 | $460.9M | $2.1B | ||
| Q3 24 | $437.9M | $619.5M | ||
| Q2 24 | $422.3M | $1.2B |
净利润PRVARITM
| Q1 26 | — | $109.5M | ||
| Q4 25 | $9.2M | $85.0M | ||
| Q3 25 | $6.9M | $221.5M | ||
| Q2 25 | $2.7M | $311.7M | ||
| Q1 25 | $4.2M | $78.8M | ||
| Q4 24 | $4.4M | $290.2M | ||
| Q3 24 | $3.5M | $121.7M | ||
| Q2 24 | $3.5M | $235.6M |
营业利润率PRVARITM
| Q1 26 | — | 29.9% | ||
| Q4 25 | 2.1% | 13.8% | ||
| Q3 25 | 2.5% | 21.4% | ||
| Q2 25 | 0.6% | 25.2% | ||
| Q1 25 | 1.1% | 7.4% | ||
| Q4 24 | 1.1% | 23.8% | ||
| Q3 24 | 1.3% | 7.3% | ||
| Q2 24 | 1.2% | 23.6% |
净利率PRVARITM
| Q1 26 | — | 13.2% | ||
| Q4 25 | 1.7% | 5.7% | ||
| Q3 25 | 1.2% | 20.0% | ||
| Q2 25 | 0.5% | 25.6% | ||
| Q1 25 | 0.9% | 10.3% | ||
| Q4 24 | 1.0% | 14.0% | ||
| Q3 24 | 0.8% | 19.7% | ||
| Q2 24 | 0.8% | 19.2% |
每股收益（稀释后）PRVARITM
| Q1 26 | — | $0.12 | ||
| Q4 25 | $0.08 | $0.09 | ||
| Q3 25 | $0.05 | $0.35 | ||
| Q2 25 | $0.02 | $0.53 | ||
| Q1 25 | $0.03 | $0.07 | ||
| Q4 24 | $0.03 | $0.50 | ||
| Q3 24 | $0.03 | $0.20 | ||
| Q2 24 | $0.03 | $0.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $479.7M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $737.2M | $9.1B |
| 总资产 | $1.4B | $53.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PRVARITM
| Q1 26 | — | — | ||
| Q4 25 | $479.7M | $1.8B | ||
| Q3 25 | $441.4M | $1.6B | ||
| Q2 25 | $390.1M | $1.6B | ||
| Q1 25 | $469.3M | $1.5B | ||
| Q4 24 | $491.1M | $1.5B | ||
| Q3 24 | $422.0M | $1.6B | ||
| Q2 24 | $387.4M | $1.2B |
总债务PRVARITM
| Q1 26 | — | — | ||
| Q4 25 | — | $35.4B | ||
| Q3 25 | — | $32.2B | ||
| Q2 25 | — | $31.2B | ||
| Q1 25 | — | $32.2B | ||
| Q4 24 | — | $32.6B | ||
| Q3 24 | — | $29.6B | ||
| Q2 24 | — | $30.1B |
股东权益PRVARITM
| Q1 26 | — | $9.1B | ||
| Q4 25 | $737.2M | $8.4B | ||
| Q3 25 | $709.1M | $8.5B | ||
| Q2 25 | $682.9M | $7.9B | ||
| Q1 25 | $659.4M | $7.8B | ||
| Q4 24 | $635.2M | $7.8B | ||
| Q3 24 | $614.9M | $7.7B | ||
| Q2 24 | $595.4M | $7.3B |
总资产PRVARITM
| Q1 26 | — | $53.4B | ||
| Q4 25 | $1.4B | $53.1B | ||
| Q3 25 | $1.4B | $47.2B | ||
| Q2 25 | $1.3B | $44.3B | ||
| Q1 25 | $1.2B | $45.3B | ||
| Q4 24 | $1.1B | $46.0B | ||
| Q3 24 | $1.1B | $42.3B | ||
| Q2 24 | $1.1B | $42.0B |
负债/权益比PRVARITM
| Q1 26 | — | — | ||
| Q4 25 | — | 4.20× | ||
| Q3 25 | — | 3.79× | ||
| Q2 25 | — | 3.92× | ||
| Q1 25 | — | 4.14× | ||
| Q4 24 | — | 4.18× | ||
| Q3 24 | — | 3.87× | ||
| Q2 24 | — | 4.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $127.5M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 13.93× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流PRVARITM
| Q1 26 | — | — | ||
| Q4 25 | $127.5M | $-114.6M | ||
| Q3 25 | $52.0M | $-2.0B | ||
| Q2 25 | $8.0M | $-557.1M | ||
| Q1 25 | $-24.1M | $1.4B | ||
| Q4 24 | $74.8M | $-1.8B | ||
| Q3 24 | $33.2M | $768.1M | ||
| Q2 24 | $34.5M | $-55.7M |
现金转化率PRVARITM
| Q1 26 | — | — | ||
| Q4 25 | 13.93× | -1.35× | ||
| Q3 25 | 7.58× | -9.22× | ||
| Q2 25 | 2.97× | -1.79× | ||
| Q1 25 | -5.70× | 18.03× | ||
| Q4 24 | 17.00× | -6.04× | ||
| Q3 24 | 9.38× | 6.31× | ||
| Q2 24 | 9.94× | -0.24× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PRVA
| FFS Patient Care | $364.4M | 67% |
| Capitated Revenue | $71.4M | 13% |
| Shared Savings | $46.9M | 9% |
| FFS Administrative Services | $36.0M | 7% |
| Care Management Fee PMPM | $20.0M | 4% |
| Other Revenue | $2.5M | 0% |
RITM
| Servicing revenue, net | $375.1M | 45% |
| Other | $234.9M | 28% |
| Gain on originated residential mortgage loans, held-for-sale, net | $195.0M | 24% |
| Other revenue | $23.3M | 3% |
